An Open-Label, Randomized, 2-Cohort, 2-Period Crossover Pharmacokinetic Study of Abaloparatide-SC and Abaloparatide-sMTS in Healthy Men and Women
Latest Information Update: 11 Jan 2022
At a glance
- Drugs Abaloparatide (Primary) ; Abaloparatide (Primary)
- Indications Male osteoporosis; Osteoporosis; Postmenopausal osteoporosis
- Focus Pharmacokinetics
- Sponsors Radius Health Inc.
- 05 Jan 2022 Status changed from active, no longer recruiting to completed.
- 08 Apr 2021 Planned End Date changed from 1 Feb 2021 to 1 Jun 2021.
- 08 Apr 2021 Status changed from recruiting to active, no longer recruiting.